Login to Your Account



Xinfu Pharma Seeks to Raise ¥1.75B to Acquire Hefei Yifan

By Shannon Ellis
Staff Writer

Wednesday, August 14, 2013

SHANGHAI -–The travails of Zhejiang Hangzhou Xinfu Pharma, a small Chinese biotech firm that lost money several years running, are a clear warning to investors.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription